FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dexamethasone Sodium Phosphate Injection
Status: Currently in Shortage
»Date first posted: 02/08/2019
»Therapeutic Categories: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology

Expand all

Eugia US LLC (Revised 11/01/2023)

Company Contact Information:
866-850-2876

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 4 mg/1 mL (NDC 55150-237-01)	On long-term backorder	Check wholesalers for inventory	Demand increase for the drug
Injection, 4 mg/1 mL (NDC 55150-238-05)	On long-term backorder	Check wholesalers for inventory	Demand increase for the drug
Injection, 4 mg/1 mL (NDC 55150-239-30)	Available
Injection, 10 mg/1 mL (NDC 55150-304-25)	Available
Injection, 100 mg/10 mL (NDC 55150-305-10)	Currently on backorder - next shipment TBD	Check wholesalers for inventory	Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 11/29/2023)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 4 mg/1 mL (NDC 76045-106-10)	Available	Check wholesalers for inventory.	Demand increase for the drug
Injection, 10 mg/1 mL (NDC 76045-109-10)	Available	Check wholesalers for inventory.	Demand increase for the drug
Injection, 4 mg/1 mL (NDC 63323-165-05)	Available	Check wholesalers for inventory.	Demand increase for the drug
Injection, 10 mg/1 mL (NDC 63323-516-10)	Next release not available at this time.	Check wholesalers for inventory.	Demand increase for the drug
Injection, 4 mg/1 mL (NDC 63323-165-30)	Available	Check wholesalers for inventory.	Demand increase for the drug
Injection, 4 mg/1 mL (NDC 63323-165-01)	Available	Check wholesalers for inventory.	Demand increase for the drug
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)	Available	Check wholesalers for inventory.	Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 05/16/2023)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)	This presentation is temporarily on backorder.	Additional lots are scheduled for manufacturing and will be available in the May - June 2023 timeframe. Product will be made available as it is released.
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)	This presentation is temporarily on backorder.	Additional lots will be scheduled for manufacturing and will be available in the June 2023 timeframe. Product will be made available as it is released.
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)	Inventory is currently available	Additional lots will be scheduled for manufacturing. Product will be made available as it is released.

Mylan Institutional, a Viatris Company (Revised 12/01/2023)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 4 mg/1 mL (NDC 67457-423-12)	Available
Injection, 4 mg/1 mL (NDC 67457-422-54)	Available
Injection, 4 mg/1 mL (NDC 67457-421-30)	Available
Injection, 10 mg/1 mL (NDC 67457-420-10)	Available

Somerset Therapeutics, LLC (Revised 11/07/2023)

Company Contact Information:
732-554-1019

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)	Limited Availability		Demand increase for the drug